India, May 18 -- FDC has received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Cefixime for Oral Suspension USP.
The approved product will be available in strengths of 100 mg/5 mL and 200 mg/5 mL, the company said in an exchange filing.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....